Full notification fileGeneral informationNotification NumberB/BE/04/BV1Member State to which the notification was sentBelgiumDate of acknowledgement from the Member State Competent Authority08/09/2004Title of the ProjectEvaluation of the safety of a Feline Herpes
virus, bivalent gene deleted live vaccine, administered as intranasal vaccination to catsProposed period of release:01/07/2004 to 01/07/2008Name of the Institute(s) or Company(ies)Pfizer Animal Health, Pfizer Animal Health
Veterinary Medicine R&D, ipc 821
Sandwich, Kent CT13 9NJ, UK;
3. Is the same GMO release planned elsewhere in the Community?Yes: Ireland; Netherlands; Has the same GMPt been notified elsewhere by the same notifier?YesIf yes, notification number(s): GMO characterizationGMO is a:DNA VirusIdentity of the GMO:The insert originates from a RNA virus.
Feline Herpes virus Type 1Information relating to the recipient or parental organisms from wich the GMO is derived
European Commission administrative informationConsent given by the Member State Competent Authority:Not known
|Feline Herpes Virus||Herpesviridae||Alphaherpesvirnae|